Article Details

Avelumab Plus Chemotherapy Fails in HNSCC Phase 3 Trial, Raises Future Research Questions

Retrieved on: 2021-04-02 18:00:00

Tags for this article:

Click the tags to see associated articles and topics

Avelumab Plus Chemotherapy Fails in HNSCC Phase 3 Trial, Raises Future Research Questions. View article details on hiswai:

Excerpt

A phase 3 trial examining the immune checkpoint inhibitor avelumab ... affects the ability of the immune system to eradicate microscopic disease.

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo